Noteworthy, PPP2R1A was among the top contributors in 13 out of 37 pathways and may therefore be a key player in driving leiomyosarcoma heterogeneity (see Figure 5 for its contribution to three selected pathways). The gene discussed is PPP2R1A; the disease is leiomyosarcoma.